Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease
Chronic kidney disease is an incurable to date pathology with a continuously growing incidence that contributes to the increase of the number of deaths worldwide. With currently no efficient prognostic or therapeutic options being available, the only possibility for treatment of end-stage renal dise...
Main Authors: | Niki Prakoura, Panagiotis Kavvadas, Christos E. Chadjichristos |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/493230 |
Similar Items
-
Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury
by: Elena Roger, et al.
Published: (2023-09-01) -
The Role of Connexin 43 in Renal Disease: Insights from In Vivo Models of Experimental Nephropathy
by: Elena Roger, et al.
Published: (2022-10-01) -
Blocking Connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease
by: Gareth W. Price, et al.
Published: (2020-05-01) -
Connexin 43: A new therapeutic target against blinding eye diseases
by: Xin-Yi Cheng, et al.
Published: (2023-03-01) -
Effects of Connexin 43 Inhibition in an Ovalbumin-induced Mouse Model of Asthma
by: Jian-Qiang Huang, et al.
Published: (2018-02-01)